These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36102692)

  • 1. Multidomain peptide hydrogel adjuvants elicit strong bias towards humoral immunity.
    Pogostin BH; Yu MH; Azares AR; Euliano EM; Lai CSE; Saenz G; Wu SX; Farsheed AC; Melhorn SM; Graf TP; Woodside DG; Hartgerink JD; McHugh KJ
    Biomater Sci; 2022 Oct; 10(21):6217-6229. PubMed ID: 36102692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Powerful Complex Immunoadjuvant Based on Synergistic Effect of Combined TLR4 and NOD2 Activation Significantly Enhances Magnitude of Humoral and Cellular Adaptive Immune Responses.
    Tukhvatulin AI; Dzharullaeva AS; Tukhvatulina NM; Shcheblyakov DV; Shmarov MM; Dolzhikova IV; Stanhope-Baker P; Naroditsky BS; Gudkov AV; Logunov DY; Gintsburg AL
    PLoS One; 2016; 11(5):e0155650. PubMed ID: 27187797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vault nanocapsules as adjuvants favor cell-mediated over antibody-mediated immune responses following immunization of mice.
    Kar UK; Jiang J; Champion CI; Salehi S; Srivastava M; Sharma S; Rabizadeh S; Niazi K; Kickhoefer V; Rome LH; Kelly KA
    PLoS One; 2012; 7(7):e38553. PubMed ID: 22808011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supramolecular peptide hydrogel adjuvanted subunit vaccine elicits protective antibody responses against West Nile virus.
    Friedrich BM; Beasley DWC; Rudra JS
    Vaccine; 2016 Nov; 34(46):5479-5482. PubMed ID: 27670075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A TLR7 Agonist Conjugated to a Nanofibrous Peptide Hydrogel as a Potent Vaccine Adjuvant.
    Euliano EM; Pogostin BH; Agrawal A; Yu MH; Baryakova TH; Graf TP; Hartgerink JD; McHugh KJ
    bioRxiv; 2024 Mar; ():. PubMed ID: 38496534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of Modified Konjac Glucomannan Nanoparticles and their Application as Vaccine Adjuvants to Promote Ovalbumin-Induced Immune Response in Mice.
    Chen N; Zhu P; Du T; Han K; Wang D; Ye J; Xiao S; Ye X; Wang Y
    Pharm Res; 2018 Mar; 35(5):105. PubMed ID: 29560565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid sequence determines the adjuvant potency of a D-tetra-peptide hydrogel.
    Zhang Y; Hu Z; Li X; Ding Y; Zhang Z; Zhang X; Zheng W; Yang Z
    Biomater Sci; 2022 Jun; 10(12):3092-3098. PubMed ID: 35522938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simple nanoliposomes encapsulating
    Bo R; Sun Y; Zhou S; Ou N; Gu P; Liu Z; Hu Y; Liu J; Wang D
    Int J Nanomedicine; 2017; 12():6289-6301. PubMed ID: 28894367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small cationic DDA:TDB liposomes as protein vaccine adjuvants obviate the need for TLR agonists in inducing cellular and humoral responses.
    Milicic A; Kaur R; Reyes-Sandoval A; Tang CK; Honeycutt J; Perrie Y; Hill AV
    PLoS One; 2012; 7(3):e34255. PubMed ID: 22470545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cubosomes containing the adjuvants imiquimod and monophosphoryl lipid A stimulate robust cellular and humoral immune responses.
    Rizwan SB; McBurney WT; Young K; Hanley T; Boyd BJ; Rades T; Hook S
    J Control Release; 2013 Jan; 165(1):16-21. PubMed ID: 23142776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injectable and Pathogen-Mimicking Hydrogels for Enhanced Protective Immunity against Emerging and Highly Pathogenic Influenza Virus.
    Noh HJ; Noh YW; Heo MB; Kim EH; Park SJ; Kim YI; Choi YK; Lim YT
    Small; 2016 Dec; 12(45):6279-6288. PubMed ID: 27671946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biotin Functionalized Self-Assembled Peptide Nanofiber as an Adjuvant for Immunomodulatory Response.
    Demircan MB; Tohumeken S; Gunduz N; Khalily MA; Tekinay T; Guler MO; Tekinay AB
    Biotechnol J; 2020 Dec; 15(12):e2000100. PubMed ID: 32679620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of injectable hydrogel properties for slow co-delivery of influenza subunit vaccine components enhance the potency of humoral immunity.
    Saouaf OM; Roth GA; Ou BS; Smith AAA; Yu AC; Gale EC; Grosskopf AK; Picece VCTM; Appel EA
    J Biomed Mater Res A; 2021 Nov; 109(11):2173-2186. PubMed ID: 33955657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvancy enhancement of muramyl dipeptide by modulating its release from a physicochemically modified matrix of ovalbumin microspheres. II. In vivo investigation.
    Puri N; Sinko PJ
    J Control Release; 2000 Oct; 69(1):69-80. PubMed ID: 11018547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of different adjuvants in the context of intramuscular and intranasal routes on humoral and cellular immune responses induced by detergent-split A/H3N2 influenza vaccines in mice.
    Baz M; Samant M; Zekki H; Tribout-Jover P; Plante M; Lanteigne AM; Hamelin ME; Mallett C; Papadopoulou B; Boivin G
    Clin Vaccine Immunol; 2012 Feb; 19(2):209-18. PubMed ID: 22190392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the Th1 cellular efficacy of the lead Yersinia pestis rF1-V subunit vaccine using SA-4-1BBL as a novel adjuvant.
    Dinc G; Pennington JM; Yolcu ES; Lawrenz MB; Shirwan H
    Vaccine; 2014 Sep; 32(39):5035-40. PubMed ID: 25045812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of AS03 and Alum on immune responses elicited by A/H3N2 split influenza vaccine in young, mature and aged BALB/c mice.
    Yam KK; Gupta J; Allen EK; Burt KR; Beaulieu É; Mallett CP; Burt DS; Ward BJ
    Vaccine; 2016 Mar; 34(12):1444-51. PubMed ID: 26873056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopotentiation of Different Adjuvants on Humoral and Cellular Immune Responses Induced by HA1-2 Subunit Vaccines of H7N9 Influenza in Mice.
    Song L; Xiong D; Hu M; Kang X; Pan Z; Jiao X
    PLoS One; 2016; 11(3):e0150678. PubMed ID: 26930068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-pot synthesis and characterization of ovalbumin-conjugated gold nanoparticles: A comparative study of adjuvanticity against the physical mixture of ovalbumin and gold nanoparticles.
    Yang Y; Zhang Y; Thakur A; Li R; Xu H; Wang Z; Ghavami M; Tu Z; Liu H
    Int J Pharm; 2019 Nov; 571():118704. PubMed ID: 31536763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-Responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides.
    Wilson JT; Keller S; Manganiello MJ; Cheng C; Lee CC; Opara C; Convertine A; Stayton PS
    ACS Nano; 2013 May; 7(5):3912-25. PubMed ID: 23590591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.